Beckman Coulter Signs Agreements With Alverno Clinical Laboratories, LLC to Provide Medical Laboratory Instruments and Supplies

Beckman Coulter, Inc. (NYSE:BEC), a leading manufacturer of diagnostics instruments in the U.S., announced it has been awarded a sole-source agreement with Alverno Clinical Laboratories, LLC, to provide a full range of hematology analyzers and supplies. Alverno is an integrated laboratory services provider jointly sponsored by Sisters of St. Francis Health Services and Provena Health, with 18 hospitals and four laboratories in Illinois and Indiana.

If all terms of the agreement are fulfilled, Alverno is expected to purchase approximately $10 million over the life of the contract. This contract covers all locations, including some that were recently added to the group through mergers with Provena Health and the Sisters of St. Francis Health Services. These locations will replace existing systems with Beckman Coulter products to achieve standardization of testing platforms throughout the network.

“Beckman Coulter is a valued business partner and the relationship is important to our success,” said Sam Terese, Alverno Clinical Laboratories Chief Operating Officer. “We are very comfortable with the technology, reliability and capabilities of the Beckman Coulter hematology line, but beyond these requirements, we look to our business partners to evaluate our operations and add value by ensuring we are using their products as effectively and productively as possible.”

Scott Garrett, Beckman Coulter president and CEO, said, “We are pleased that Alverno will offer its members hematology instrument systems and supplies from Beckman Coulter. Our innovative solutions will help Alverno facilities simplify and automate their processes to further increase their laboratories’ efficiency, helping to lower overall healthcare costs.”